Mesa Laboratories (NASDAQ:MLAB) Raised to “Buy” at Wall Street Zen

Mesa Laboratories (NASDAQ:MLAB) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday.

Several other analysts also recently commented on the company. Weiss Ratings reiterated a “sell (d)” rating on shares of Mesa Laboratories in a research note on Wednesday, October 8th. Wells Fargo & Company raised Mesa Laboratories from an “underweight” rating to an “equal weight” rating and lowered their price target for the company from $100.00 to $67.00 in a report on Thursday, August 7th. Finally, Zacks Research upgraded Mesa Laboratories from a “strong sell” rating to a “hold” rating in a report on Monday, August 18th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus target price of $67.00.

Mesa Laboratories Stock Up 1.5%

Shares of NASDAQ:MLAB traded up $1.14 during trading on Friday, reaching $76.01. 309,752 shares of the stock traded hands, compared to its average volume of 99,531. The stock has a market cap of $418.21 million, a P/E ratio of -542.93 and a beta of 0.89. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.47 and a current ratio of 0.66. The stock has a 50-day moving average of $70.14 and a two-hundred day moving average of $85.26. Mesa Laboratories has a 52-week low of $55.45 and a 52-week high of $155.12.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Farther Finance Advisors LLC increased its stake in shares of Mesa Laboratories by 17,733.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 535 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 532 shares in the last quarter. CWM LLC grew its holdings in Mesa Laboratories by 48.9% during the third quarter. CWM LLC now owns 597 shares of the medical instruments supplier’s stock valued at $40,000 after purchasing an additional 196 shares during the period. State of Wyoming increased its position in Mesa Laboratories by 501.4% in the first quarter. State of Wyoming now owns 427 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 356 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Mesa Laboratories in the first quarter worth about $67,000. Finally, BNP Paribas Financial Markets lifted its position in shares of Mesa Laboratories by 115.3% during the 2nd quarter. BNP Paribas Financial Markets now owns 786 shares of the medical instruments supplier’s stock valued at $74,000 after buying an additional 421 shares in the last quarter. Hedge funds and other institutional investors own 90.60% of the company’s stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.